147 related articles for article (PubMed ID: 27677656)
21. Obesity as the initial manifestation of central nervous system relapse of acute lymphoblastic leukemia: case report and literature review.
Zhang LD; Li YH; Ke ZY; Huang LB; Luo XQ
J Cancer Res Ther; 2012; 8(1):151-3. PubMed ID: 22531539
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
[TBL] [Abstract][Full Text] [Related]
23. Myelomatous Involvement of the Central Nervous System.
Paludo J; Painuly U; Kumar S; Gonsalves WI; Rajkumar V; Buadi F; Lacy MQ; Dispenzieri A; Kyle RA; Mauermann ML; McCurdy A; Dingli D; Go RS; Hayman SR; Leung N; Lust JA; Lin Y; Gertz MA; Kapoor P
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):644-654. PubMed ID: 27624224
[TBL] [Abstract][Full Text] [Related]
24. CSF analysis of IgH gene rearrangement in CNS lymphoma: relationship to the disease course.
Ekstein D; Ben-Yehuda D; Slyusarevsky E; Lossos A; Linetsky E; Siegal T
J Neurol Sci; 2006 Aug; 247(1):39-46. PubMed ID: 16678210
[TBL] [Abstract][Full Text] [Related]
25. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry.
Roma AA; Garcia A; Avagnina A; Rescia C; Elsner B
Diagn Cytopathol; 2002 Nov; 27(5):271-5. PubMed ID: 12411991
[TBL] [Abstract][Full Text] [Related]
26. Cytodiagnosis of neoplasms of the central nervous system in cerebrospinal fluid samples with an application of selective immunostains in differentiation.
Gupta RK; Naran S; Lallu S; Fauck R
Cytopathology; 2004 Feb; 15(1):38-43. PubMed ID: 14748790
[TBL] [Abstract][Full Text] [Related]
27. Lymphomatous meningitis: early diagnosis and treatment.
Van Horn A
Clin J Oncol Nurs; 2009 Feb; 13(1):90-4. PubMed ID: 19193553
[TBL] [Abstract][Full Text] [Related]
28. Primary CNS lymphoma and neurologic complications of hematologic malignancies.
Nayak L; Pentsova E; Batchelor TT
Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):355-72. PubMed ID: 25837901
[TBL] [Abstract][Full Text] [Related]
29. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
30. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.
Schinstine M; Filie AC; Wilson W; Stetler-Stevenson M; Abati A
Cancer; 2006 Jun; 108(3):157-62. PubMed ID: 16649227
[TBL] [Abstract][Full Text] [Related]
31. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
[TBL] [Abstract][Full Text] [Related]
32. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
[TBL] [Abstract][Full Text] [Related]
33. Optimization of CSF biological investigations for CNS lymphoma diagnosis.
Armand M; Costopoulos M; Osman J; Tarfi S; Houillier C; Choquet S; Agnelo H; Bonnemye P; Ronez E; Settegrana C; Soussain C; Hoang-Xuan K; Le Garff-Tavernier M; Davi F
Am J Hematol; 2019 Oct; 94(10):1123-1131. PubMed ID: 31328307
[TBL] [Abstract][Full Text] [Related]
34. Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients.
Subirá D; Górgolas M; Castañón S; Serrano C; Román A; Rivas F; Tomás JF
HIV Med; 2005 Jan; 6(1):21-6. PubMed ID: 15670248
[TBL] [Abstract][Full Text] [Related]
35. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease.
Liao B; Kamiya-Matsuoka C; Gong Y; Chen M; Wolf BA; Fowler NH
J Neurol Sci; 2014 Aug; 343(1-2):46-50. PubMed ID: 24880537
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
37. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
39. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
